Published Date: 17 Feb 2023
A man takes a small pill before hoping to flirt with his girlfriend.
Read Full NewsDrs Marwah Abdalla and Lewis Blevins discuss Cushing syndrome: Why it is frequently missed, how clinicians can screen for it, and how to manage it.
An overview of MASLD, including the epidemiology, diagnostic approaches, and therapeutic options highlighting the cardiologists’ role in its multidisciplinary management.
Listener feedback, huge news in the rapidly expanding world of PFA AF Ablation, obesity, and a beautiful trial studying an AI-enhanced diagnostic tool in the office are the topics discussed by John Mandrola, MD, in this week’s podcast.
A crossover trial to determine whether ketone ester improves exercise tolerance in HFpEF.
Problems with the PREVENT score, a breakthrough in lipid-lowering therapy, a surprising benefit in stroke care, and more thoughts on statins and preventive care of heart disease are the topics John Mandrola, MD, discusses in this week’s podcast.
Citing The Death of Ivan Ilyich, the authors call for professional societies to jointly embrace a core definition of frailty for cardiovascular care and clinical practice.
A phase 2 study evaluates the safety and efficacy of brentuximab vedotin and nivolumab plus chemotherapy in patients with early-stage classical Hodgkin lymphoma.
1.
In CML Patients With New Diagnoses, STAMP Inhibitor Outperforms Imatinib and Second-Gen TKIs.
2.
New imaging solution could help improve survival for patients with recurring prostate cancer
3.
Study offers clearer picture of childhood brain tumor survival
4.
Short Shrift in Cancer Funding; Bypassing Familiar for Distant; Testing for BRCA.
5.
Clinical trial could lead to new 'gold standard' test for prostate cancer detection
1.
Cracking the Code of Subdural Hematomas: Modern Strategies for Optimal Care
2.
Improving TIVAP Use: Review of Standardization and Optimization Practices
3.
A Closer Look at Breast Cancer: Examining the Ultrasound Images
4.
Uncovering the Mystery of Burkitt's Lymphoma: A New Hope for Treatment
5.
Understanding the Importance of Knowing Your MCV Normal Range
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV
2.
Updates on Standard V/S High Risk Myeloma Treatment
3.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
5.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation